3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Polycystic Ovary Syndrome
2
Obesity
1
Adenocarcinoma of Lung
1
Interventions
Carboplatin
36
Pemetrexed
28
Bevacizumab
26
Cisplatin
24
Paclitaxel
22
Gemcitabine
20
Radiotherapy
18
Docetaxel
18
Erlotinib Hydrochloride
15
Gefitinib
11
pembrolizumab
6
Cetuximab
6
capmatinib
5
Surgical Procedures, Operative
5
Radiosurgery
5
aflutinib
4
Vinorelbine
4
Taxes
4
Platinum
4
Nivolumab
4
Metformin
4
pegfilgrastim
3
durvalumab
3
ceritinib
3
apatinib
3
Sorafenib
3
Radiation
3
Neoadjuvant Therapy
3
Magnetic Resonance Spectroscopy
3
tislelizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Adenocarcinoma of Lung
×
Orlistat
×
Clear all
NCT06818955
2025-02-12
OOTER
Tongji Hospital
Phase 2
Not yet recruiting
36 enrolled